FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
1-Year Return
23.12%
This Quarter Return
-0.09%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$17.9B
AUM Growth
-$687M
(-3.7%)
Cap. Flow
+$50M
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
39.72%
Holding
164
New
17
Increased
41
Reduced
26
Closed
19
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$403M |
| 2 |
Microsoft
MSFT
|
+$245M |
| 3 |
Salesforce
CRM
|
+$203M |
| 4 |
Aramark
ARMK
|
+$167M |
| 5 |
Walt Disney
DIS
|
+$105M |
Top Sells
| 1 |
Airbnb
ABNB
|
+$319M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$221M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$180M |
| 4 |
HES
Hess
HES
|
+$163M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$142M |
Sector Composition
| 1 | Healthcare | 42.73% |
| 2 | Technology | 17.47% |
| 3 | Financials | 14.39% |
| 4 | Communication Services | 7.16% |
| 5 | Industrials | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Protagonist Therapeutics
PTGX
$3.62B
| $295M | 1.46% |
6,107,006
+177,000
| +3% | +$8.56M |
|
27
Wabtec
WAB
$32.4B
| $292M | 1.45% |
1,608,098
+177,900
| +12% | +$32.3M |
|
28
iShares Bitcoin Trust
IBIT
$83.4B
| $271M | 1.35% |
5,793,800
-1,465,300
| -20% | -$68.6M |
|
29
Analog Devices
ADI
$122B
| $268M | 1.33% |
1,327,000
+169,800
| +15% | +$34.2M |
|
30
Alphabet (Google) Class C
GOOG
$2.89T
| $260M | 1.29% |
1,666,040
-414,500
| -20% | -$64.8M |
|
31
Woodward
WWD
$14.3B
| $259M | 1.29% |
1,419,700
-101,600
| -7% | -$18.5M |
|
32
Hims & Hers Health
HIMS
$10.8B
| $235M | 1.17% |
7,953,705
-423,295
| -5% | -$12.5M |
|
33
BridgeBio Pharma
BBIO
$10.2B
| $198M | 0.98% |
5,731,000
+1,536,000
| +37% | +$53.1M |
|
34
Beam Therapeutics
BEAM
$2.01B
| $194M | 0.96% |
9,928,111
+1,688,988
| +20% | +$33M |
|
35
Agios Pharmaceuticals
AGIO
$2.12B
| $167M | 0.83% |
5,700,466
+26,000
| +0.5% | +$762K |
|
36
Visa
V
$670B
| $166M | 0.82% |
474,210
-75,300
| -14% | -$26.4M |
|
37
Crinetics Pharmaceuticals
CRNX
$3.45B
| $154M | 0.77% |
4,605,098
+530,000
| +13% | +$17.8M |
|
38
Sarepta Therapeutics
SRPT
$1.83B
| $149M | 0.74% |
2,341,424
-523,676
| -18% | -$33.4M |
|
39
Biohaven
BHVN
$1.54B
| $116M | 0.57% |
4,813,167
+385,000
| +9% | +$9.26M |
|
40
Mastercard
MA
$531B
| $110M | 0.55% |
201,371
-94,300
| -32% | -$51.7M |
|
41
Full Truck Alliance
YMM
$13.9B
| $94M | 0.47% |
7,357,207
-9,227,888
| -56% | -$118M |
|
|
X
42
DELISTED
US Steel
X
| $90.2M | 0.45% |
2,135,000
-1,641,000
| -43% | -$69.3M |
|
|
CHX
43
DELISTED
ChampionX
CHX
| $86.6M | 0.43% |
2,905,000
-930,000
| -24% | -$27.7M |
|
|
SGI
44
Somnigroup International Inc.
SGI
$17.8B
| $79.4M | 0.39% |
+1,326,242
| New | +$79.4M |
|
|
WAY
45
Waystar Holding Corp
WAY
$7.03B
| $75.5M | 0.37% |
2,020,000
+678,000
| +51% | +$25.3M |
|
|
VRNA
46
Verona Pharma
VRNA
$9.19B
| $68.9M | 0.34% |
+1,084,989
| New | +$68.9M |
|
47
Encompass Health
EHC
$12.6B
| $62.7M | 0.31% |
619,000
+158,000
| +34% | +$16M |
|
48
New Oriental
EDU
$8.51B
| $62.4M | 0.31% |
1,305,150
-1,054,000
| -45% | -$50.4M |
|
|
CNTA
49
Centessa Pharmaceuticals
CNTA
$2.67B
| $62.3M | 0.31% |
4,334,318
+835,609
| +24% | +$12M |
|
50
Liquidia Corp
LQDA
$2.41B
| $58.9M | 0.29% |
3,990,956
+700,000
| +21% | +$10.3M |
|